Cargando…
Arrhythmic Effects Evaluated on Caenorhabditis elegans: The Case of Polypyrrole Nanoparticles
[Image: see text] Experimental studies and clinical trials of nanoparticles for treating diseases are increasing continuously. However, the reach to the market does not correlate with these efforts due to the enormous cost, several years of development, and off-target effects like cardiotoxicity. Mu...
Autores principales: | Srinivasan, Sumithra Yasaswini, Illera, Pilar Alvarez, Kukhtar, Dmytro, Benseny-Cases, Núria, Cerón, Julián, Álvarez, Javier, Fonteriz, Rosalba I., Montero, Mayte, Laromaine, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510705/ https://www.ncbi.nlm.nih.gov/pubmed/37624669 http://dx.doi.org/10.1021/acsnano.3c05245 |
Ejemplares similares
-
Modeling Alzheimer’s Disease in Caenorhabditis elegans
por: Alvarez, Javier, et al.
Publicado: (2022) -
The Role of Ca(2+) Signaling in Aging and Neurodegeneration: Insights from Caenorhabditis elegans Models
por: Alvarez, Javier, et al.
Publicado: (2020) -
SERCA inhibition improves lifespan and healthspan in a chemical model of Parkinson disease in Caenorhabditis elegans
por: Romero-Sanz, Silvia, et al.
Publicado: (2023) -
Mitochondrial Ca(2+) Dynamics in MCU Knockout C. elegans Worms
por: Álvarez-Illera, Pilar, et al.
Publicado: (2020) -
The Mitochondrial Na(+)/Ca(2+) Exchanger Inhibitor CGP37157 Preserves Muscle Structure and Function to Increase Lifespan and Healthspan in Caenorhabditis elegans
por: García-Casas, Paloma, et al.
Publicado: (2021)